UK markets close in 1 hour 38 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
8,358.00+10.00 (+0.12%)
As of 2:37PM BST. Market open.
Currency in GBp

Valuation measures

Market cap (intra-day) 5109.72B
Enterprise value 3124.26B
Trailing P/E 38.93
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)3.98
Price/book (mrq)759.87
Enterprise value/revenue 34.51
Enterprise value/EBITDA 718.46

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 3-1.92%
S&P500 52-week change 336.18%
52-week high 310,120.00
52-week low 36,499.80
50-day moving average 37,900.47
200-day moving average 37,525.24

Share statistics

Avg vol (3-month) 32.68M
Avg vol (10-day) 32.62M
Shares outstanding 51.31B
Implied shares outstanding 6N/A
Float 1.31B
% held by insiders 10.33%
% held by institutions 153.71%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.07
Forward annual dividend yield 42.48%
Trailing annual dividend rate 32.80
Trailing annual dividend yield 30.03%
5-year average dividend yield 43.59
Payout ratio 493.81%
Dividend date 3N/A
Ex-dividend date 425 Feb 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Mar 2021

Profitability

Profit margin 14.42%
Operating margin (ttm)14.85%

Management effectiveness

Return on assets (ttm)4.19%
Return on equity (ttm)29.67%

Income statement

Revenue (ttm)27.58B
Revenue per share (ttm)21.02
Quarterly revenue growth (yoy)15.20%
Gross profit (ttm)21.37B
EBITDA 6.73B
Net income avi to common (ttm)3.98B
Diluted EPS (ttm)214.70
Quarterly earnings growth (yoy)100.10%

Balance sheet

Total cash (mrq)7.77B
Total cash per share (mrq)5.92
Total debt (mrq)22.49B
Total debt/equity (mrq)155.65
Current ratio (mrq)0.87
Book value per share (mrq)11.00

Cash flow statement

Operating cash flow (ttm)6.59B
Levered free cash flow (ttm)5.12B